1.180USD-6.34%Mkt Cap: 37.02M USDP/E: —Last update: 2026-06-01
Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap37.02M USD
Enterprise Value-4.53M USD
Revenue (TTM)90.00K USD
Gross Profit90.00K USD
Net Income (TTM)-33.89M USD
Revenue/Share0.0030 USD
Last Price1.180 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees25
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.64
PEG—
EV/EBITDA0.18
EV/Revenue-50.35
P/S439.25
P/B17.26
EPS (TTM)-0.76
EPS (Forward)-0.48
52W Range
0.952023% of range1.945
52W High1.945 USD
52W Low0.9520 USD
Profitability
Gross Margin100.00%
Oper. Margin-28346.67%
EBITDA Margin0.00%
Profit Margin-37652.22%
ROE-432.56%
ROA-65.45%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.58M USD
CapEx (TTM)104.00K USD
FCF Margin-6586.67%
FCF Yield-16.01%
Net Debt-40.61M USD
Net Debt/EBITDA1.60
Balance Sheet
Debt/Equity0.22
Current Ratio5.89
Quick Ratio5.73
Book Value/Sh0.0730 USD
Cash/Share1.343 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 11, 2020
Splits
Last Split1:30
Split DateAug 11, 2020
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Target Range2.000 USD – 9.000 USD
# Analysts5
Ownership
Shares Out.31.37M
Float31.04M
Insiders2.35%
Institutions20.61%
Short Interest
Short Ratio4.0d
Short % Float3.36%
Short % Out.3.34%
Shares Short1.05M
Short (prev mo.)1.09M
Technical
SMA 501.182 (-0.1%)
SMA 2001.362 (-13.3%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)193.97K
Avg Vol (10d)79.71K
Technical Indicators
RSI (14)55.3
MACD-0.0068
MACD Signal-0.0019
MACD Hist.-0.0048
BB Upper1.345 USD
BB Middle1.221 USD
BB Lower1.096 USD
BB Width20.42%
ATR (14)0.0700 USD
Vol Ratio (20d)1.34x